A Study to Assess the Efficacy and Safety of THB335 in Adults With Chronic Spontaneous Urticaria (CSU)

Clinical trial NCT07766499 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07766499
Sponsor: Calixis Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Spontaneous Urticaria (CSU)Chronic Idiopathic Urticaria

Start date: 2026-09-01
Primary completion: 2027-12-31
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.